Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
1997

Prognostic Factors in Colorectal Cancer

Sample size: 136 publication 10 minutes Evidence: moderate

Author Information

Author(s): S Ganesh, CFM Sier, MM Heerding, JHJM van Krieken, G Griffioen, K Welvaart, CJH van de Velde, JH Verheijen, CBHW Lamers, HW Verspaget

Primary Institution: University Hospital Leiden

Hypothesis

Can plasminogen activators and their inhibitors serve as prognostic indicators for patients with Dukes' stage B and C colorectal cancer?

Conclusion

The study found that certain plasminogen activation parameters are significantly associated with poor overall survival in colorectal cancer patients.

Supporting Evidence

  • A high PAI-2 antigen level in carcinoma is associated with poor overall survival.
  • A low t-PA activity and antigen level in normal mucosa are linked to poor survival.
  • The u-PA/t-PA antigen ratio in normal mucosa is a significant prognostic factor.
  • Combinations of plasminogen activation parameters provide better prognostic indicators than individual parameters.

Takeaway

Doctors can use specific proteins in the body to help predict how well patients with colorectal cancer will do after treatment.

Methodology

The study evaluated plasminogen activation parameters in tissue samples from colorectal cancer patients and analyzed their association with overall survival.

Limitations

The study was limited to patients with Dukes' stage B and C colorectal cancer and may not apply to other stages or types of cancer.

Participant Demographics

60 women and 76 men, mean age 68.3 years.

Statistical Information

P-Value

0.004

Confidence Interval

95% CI

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication